Financials
- Market Capitalization 103.16 M
- Employee 220
- Founded 2002
- CEO N/A
- Website www.exagen.com
- Headquarter Delaware, United States
- FIGI BBG00178FZY1
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3801 | IMDX Insight Molecular Diagnostics Inc. - Common Stock | 4.70 USD | +5.38% | -0.84% | -17.54% | +64.91% | 151.76 M USD | ||
| 3868 | STIM Neuronetics, Inc. - Common Stock | 1.86 USD | +5.08% | +20.78% | +46.46% | -50.13% | 129.43 M USD | ||
| 3975 | BNR Burning Rock Biotech Limited - American Depositary Shares | 9.35 USD | -4.59% | -19.95% | +2.97% | -68.75% | 101.17 M USD | ||
| 4302 | DRIO DarioHealth Corp. - Common Stock | 6.75 USD | +3.37% | -6.90% | -2.32% | -39.57% | 49.36 M USD |
Frequently asked questions about Exagen Inc. - Common Stock
What is the Exagen Inc. - Common Stock stock price today?
The current price of Exagen Inc. - Common Stock (XGN) is 4.27. Over the past 24 hours, the stock has changed by +4.40%. Follow the XGN chart for real-time price dynamics.
What is the stock ticker of Exagen Inc. - Common Stock?
Exagen Inc. - Common Stock trades under the ticker XGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Exagen Inc. - Common Stock stock going up?
XGN has changed by -4.90% over the last week, -7.38% over the last month, and -37.48% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Exagen Inc. - Common Stock net income for the last quarter?
Exagen Inc. - Common Stock reported net income of -3.97 M for the last quarter. The previous quarter showed -4.67 M, which means net income changed by +15.11%.
How many employees does Exagen Inc. - Common Stock have?
As of the latest available data, Exagen Inc. - Common Stock has 220 employees. Workforce size can provide additional context about the company's scale and operations.
What is Exagen Inc. - Common Stock EBITDA?
Exagen Inc. - Common Stock EBITDA is 4.29 M, and its EBITDA margin is 24.77%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Exagen Inc. - Common Stock stock?
You can buy Exagen Inc. - Common Stock (XGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Exagen Inc. - Common Stock stock?
Investing in Exagen Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XGN chart and related analysis on metatrader.com as part of your research.